Hygieia Inc.

Article preview from Start Up- November 01, 2010

An urgent need exists for a simple and cost-effective way to support insulin therapy, mainly for people with type 2 diabetes, in between physician check-ups. Hygieia Inc. plans on addressing this need in a big way with its patient- and clinician-friendly Diabetes Insulin Guidance System (DIGS), designed to replace commonly used glucose meters that simply provide blood sugar readings. Hygieia's DIGS device is designed to support diabetes patients' glycemic control by providing them with with simple dose-by-dose insulin recommendations.

Hygieia Inc.

Article preview from Start Up- November 01, 2010

The American Diabetes Association (ADA) estimates that roughly 24 million people in the US – 7.8% of the population – have diabetes. Approximately six million of these cases are undiagnosed. Another 1.6 million new cases are diagnosed each year. Even more daunting, an estimated 57 million Americans, most of them obese, have prediabetes, meaning that without intervention their condition is likely to develop into diabetes in 10 years or less.

Of the approximately 5.5 million Americans who manage their diabetes with daily insulin injections, two-thirds do not achieve adequate control over their constantly fluctuating blood sugar levels, according to the Centers for Disease Control & Prevention. Along with their health care providers, they are continuously struggling to achieve glycemic control, which is defined as maintaining glucose levels within a normal range and an ADA-recommended glycated hemoglobin (A1C) level of less than 7%. Lack of glycemic control often leads to serious health complications affecting the heart, blood vessels, eyes, kidneys and nervous system, which cost the already-strained US health care system over $100 billion per year.

Purchase this article online or get it FREE when you subscribe to Start Up

Elsevier Business Intelligence announces the publication of a new Special Report "Bigger, Tougher,Faster"- Preparing for the New FDA. When the inspector comes calling ... will you be ready?


This 16-page report originally published in "The Silver Sheet". Learn more... 
About Start Up

No publication reviews leading edge companies and technology better than START-UP. Each issue of START-UP profiles the most important new product companies, identifies the hottest technology areas, reviews funds flowing into private companies and investment trends, and reports on university tech transfer licensing. Industries covered: pharmaceuticals, biotechnology, medical equipment & devices, and in vitro diagnostics.

Plus:
To find out about more about more about Elsevier Business Intelligence's medical device publications and databases, multi-user access and/or advertising with Medical Devices Today, please contact Kristy Kennedy at (480) 985 9512